UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049073
Receipt number R000055885
Scientific Title Study of continuous ingestion of protein powder
Date of disclosure of the study information 2022/09/30
Last modified on 2023/03/31 09:57:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of continuous ingestion of protein powder

Acronym

Study of continuous ingestion of protein powder

Scientific Title

Study of continuous ingestion of protein powder

Scientific Title:Acronym

Study of continuous ingestion of protein powder

Region

Japan


Condition

Condition

None

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the effect of test food intake on exercise performance

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Endurance performance evaluation

Key secondary outcomes

Body composition
Nutrient intake status
Hematologic test
Blood biochemical test
Visual Analogue Scale
Rating of Perceived Exertion
Height


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Ingestion of test food (for 6 weeks)

Interventions/Control_2

Ingestion of placebo food (for 6 weeks)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

30 years-old >

Gender

Male

Key inclusion criteria

University athletic club members who have been participating in conditioning support for a long time are recruited orally and in writing, and those who have obtained consent are eligible.

Key exclusion criteria

Individuals who are with food allergies, have a habit of smoking, ingest test ingredients on a daily basis, or are anemic.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Naomi
Middle name
Last name Omi

Organization

University of Tsukuba

Division name

Faculty of Health and Sport Sciences

Zip code

305-8574

Address

1-1-1, Tennou dai, Tsukuba city

TEL

029-853-6319

Email

omi.naomi.gn@u.tsukuba.ac.jp


Public contact

Name of contact person

1st name Naomi
Middle name
Last name Omi

Organization

University of Tsukuba

Division name

Faculty of Health and Sport Sciences

Zip code

305-8574

Address

1-1-1, Tennou dai, Tsukuba city

TEL

029-853-6319

Homepage URL


Email

omi.naomi.gn@u.tsukuba.ac.jp


Sponsor or person

Institute

University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

MORINAGA & CO., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research ethics committee,Faculty of Health and Sport Sciences,University of Tsukuba

Address

1-1-1 Tennodai, Tsukuba,Ibaraki

Tel

029-853-2571

Email

tg-kenkyurinri@un.tsukuba.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 09 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

25

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 08 Month 05 Day

Date of IRB

2022 Year 09 Month 26 Day

Anticipated trial start date

2022 Year 10 Month 03 Day

Last follow-up date

2022 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 09 Month 30 Day

Last modified on

2023 Year 03 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000055885


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name